Due to the importance of the IDH gene for glioma formation and prognosis, the 2021 WHO Classification of Tumors of the Central Nervous System classifies WHO grade 4 gliomas into WHO grade 4 IDH-mutant astrocytoma and IDH-wildtype GBM4. This evidence concerns the gene IDH1 and glioma.